You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ovarian carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

Not yet recruiting
  • Relapsed Ovarian Cancer
  • (no location specified)
Oct 7, 2023

Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

Completed
  • Serous Ovarian Carcinoma
  • Low Grade Serous Ovarian Carcinoma
  • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
  • Lyon, France
    Hospices civils de Lyon
Feb 14, 2023

Epithelial Cell Adhesion Molecule in Epithelial Ovarian

Recruiting
  • Ovarian Carcinoma
    • Sohag, Egypt
    • +1 more
    Oct 8, 2022

    Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

    Not yet recruiting
    • Ovarian Carcinoma
    • PEP-DC1
    • +3 more
    • (no location specified)
    Jan 26, 2023

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +5 more
    • Biopsy
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Relapsed Ovarian Cancer Trial (Fluzoparib+Apatinib, Fluzoparib Monotherapy)

    Not yet recruiting
    • Relapsed Ovarian Cancer
    • (no location specified)
    Jul 27, 2022

    Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

    Recruiting
    • Advanced Ovarian Carcinoma
    • +7 more
    • Bydgoszcz, Kujawsko-pomorskie, Poland
    • +2 more
    Mar 7, 2023

    Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • +2 more
    • Mobile, Alabama
    • +7 more
    Jan 24, 2023

    Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

    Not yet recruiting
    • Ovarian Carcinoma
    • Sacituzumab govitecan
    • New Haven, Connecticut
      Smilow Cancer Hospital at Yale New Haven
    Aug 31, 2023

    Patients With Low Grade Ovarian or Peritoneal Tumors

    Recruiting
    • Low Grade Ovarian Serous Adenocarcinoma
    • +5 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Ovarian Carcinoma
    • XP-DC vaccinations
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Mar 6, 2023

    Ovarian Carcinoma Trial (Presence of sarcopenia evaluated prior to neoadjuvant chemo and during chemo as part of optimised

    Not yet recruiting
    • Ovarian Carcinoma
    • Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).
    • (no location specified)
    Jun 10, 2022

    Sentinel Lymph Node, Ovarian Carcinoma Trial in Istanbul (Sentinel lymph node biopsy (using sterile charcoal stain) in early

    Recruiting
    • Sentinel Lymph Node
    • Ovarian Carcinoma
    • Sentinel lymph node biopsy (using sterile charcoal stain) in early ovarian cancer
    • Istanbul, Turkey
      Istanbul University
    Jun 25, 2023

    Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Recruiting
    • Ovarian Carcinoma
    • Biospecimen Collection
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 5, 2023

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Durvalumab
    • Tremelimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 19, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Completed
    Has Results
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Bevacizumab
    • Irinotecan Sucrosofate
    • Chicago, Illinois
      Northwestern University
    Dec 21, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

    Recruiting
    • Malignant Ovarian Epithelial Tumor
    • +9 more
    • Akt/ERK Inhibitor ONC201
    • +2 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    May 10, 2022

    Ovarian Carcinoma Trial in Tanta (Itraconazole capsule, Placebo)

    Not yet recruiting
    • Ovarian Carcinoma
    • Itraconazole capsule
    • Placebo
    • Tanta, Egypt
      Tanta University, Faculty of Pharmacy
    Oct 20, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +6 more
    • Biopsy
    • Pegylated SN-38 Conjugate PLX038
    • Rochester, Minnesota
      Mayo Clinic
    Jul 19, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

    Recruiting
    • Advanced Fallopian Tube Carcinoma
    • +21 more
    • Biopsy
    • +2 more
    • Bethesda, Maryland
    • +2 more
    Jan 25, 2023